Mountain View, California-based Second Opinion Health is seeing strong feedback since recently exiting stealth mode for release of its first product Migraine Alert , an app that provides personalized predictions of migraine episodes for people with intermittent migraines. The company's app, currently being offered direct to consumers, is being studied at the Mayo Clinic in trials backed by pharmaceutical company Allergan.
Mountain View, California-based Second Opinion Health is seeing strong feedback since recently exiting stealth mode for release of its first product Migraine Alert , an app that provides personalized predictions of migraine episodes for people with intermittent migraines. The company's app, currently being offered direct to consumers, is being studied at the Mayo Clinic in trials backed by pharmaceutical company Allergan.
No comments:
Post a Comment